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A full understanding of the immune sys-
tem requires full characterization of the 
cells, and its subsets, which play a role in 
the process of host defense. The expression 
pattern of cell surface molecules serves as 
a major criterion for assigning cells into 
discrete subsets. The availability of mono-
clonal reagents, specific fluorescent probes 
and compatible instrumentation over the 
past years has led to identification and 
characterization of a great number of leu-
kocyte subsets, including monocyte subsets, 
recently reviewed by Ziegler-Heitbrock and 
Hofer (1).
When using flow cytometry, human 
blood monocytes are characterized by 
forward and side scatter as well as the 
expression of the LPS coreceptor CD14 
and the Fcgamma receptor III CD16 
(2). Based on the relative expression of 
CD14 and CD16, monocytes used to be 
subdivided in classical monocytes and 
CD16 expressing monocytes, of which 
the latter population is expanded in vari-
ous diseases (3) [reviewed by Ref. (4)]. 
In 2008, a group of experts proposed (a 
nomenclature for) three subsets of blood 
monocytes: classical (CD14++CD16−), 
intermediate (CD14++CD16+), and non-
classical (CD14+CD16++) (5). Since then, 
additional evidence from gene  expression 
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 underscored the existence of three mono-
cyte subsets (6, 7).
Recently, Ziegler-Heitbrock and Hofer 
(1) presented an elegant review where they 
emphasized the importance of a refined 
analysis of the three different monocyte 
subsets. Intermediate monocytes are eas-
ily overlooked because of their small num-
bers and (inherent) transitional nature. It 
is still unknown if intermediate monocytes 
have a discrete, biologically meaningful 
role or whether they are the unavoidable 
intermediates in an otherwise continuous 
differentiation from classical into non-
classical monocytes. Although the func-
tion of intermediate monocytes is not 
known, they could be important to tailor 
immune response in different pathologies, 
because intermediate monocytes have been 
found increased in certain conditions: in 
rheumatoid arthritis (8) and patients with 
severe asthma (9), intermediate monocytes 
are responsible for the increase in CD16 
expressing monocytes. Recently, we have 
published that intermediate monocytes 
in blood are also increased in sarcoidosis 
(3.08 ± 0.25 versus 1.98 ± 0.22% in healthy 
controls; P = 0.017) (10).
Ziegler-Heitbrock and Hofer (1) cor-
rectly conclude that specific markers for 
the intermediate monocytes are required in 
order to unequivocally identify and enumer-
ate this subset. In fact, data from our labora-
tory indicate that relative expression of TNF 
receptors and CC chemokine receptors can 
be used to further characterize intermedi-
ate monocytes. TNF is a major cytokine 
regulating the activity of  monocytes and 
chemokines are essential for the selective 
recruitment of different leukocyte subsets to 
inflammatory sites. Therefore an extended 
phenotypic characterization of mono-
cyte subsets, which includes expression of 
TNFR1, TNFR2, CCR2, and CCR5, can 
contribute to a more robust identification 
of intermediate monocytes.
In our experiments, we investigated the 
expression of TNFR1, TNFR2, HLA-DR, 
CCR2, and CCR5 on monocyte subsets 
using similar flow cytometric methods as 
proposed by Ziegler-Heitbrock and Hofer 
(1). In a four color set-up, cells were stained 
with anti-HLA-DR, CD14, CD16, and either 
TNFR1, TNFR2, CCR2, or CCR5. After 
staining, flow cytometry data were acquired 
on a FACSCalibur (BD Biosciences) and 
analyzed using FlowJo software (Tree Star, 
Ashland, OR, USA). Monocytes were gated 
based on forward × side scatter and side scat-
ter × HLA-DR+ expression. Subsequently, 
monocytes were subdivided in 10 popula-
tions based on a gradual increasing CD16 
and a decreasing CD14 expression pattern 
(Figure 1A). The multistep gating of inter-
mediate and non-classical monocytes was 
used in order to obtain a more detailed pic-
ture of how the expression of TNFRs and 
CCRs will develop.
All blood monocytes, from normal 
healthy donors as well as from patients 
with sarcoidosis, expressed TNFR1. 
Highest expression of TNFR1 was found 
on intermediates (P < 0.01; Figure 1B). 
All monocytes also expressed TNFR2, but 
the three subsets showed major differ-
ences in TNFR2 expression (P < 0.0001; 
Figure 1C). Non-classical monocytes 
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expressed the highest levels of TNFR2. 
Intermediates expressed less TNFR2 than 
non-classicals, but more than classicals. 
All monocytes expressed HLA-DR, but 
intermediate monocytes showed clearly a 
higher expression than classical and non-
classical (P < 0.0001; Figure 1D). Classical 
monocytes showed a high expression of 
CCR2, whereas non-classicals showed very 
low expression (Figure 1E). Intermediates 
did express CCR2, but in a lower level 
than classical. Intermediate monocytes 
also expressed the highest levels of CCR5 
(Figure 1F). These data therefore indicate 
that intermediate monocytes differ from 
other monocyte subsets in expression lev-
els of TNFR1, HLA-DR, CCR2, and CCR5.
FiguRe 1 | Differential expression of TNFR1, TNFR2, HLA-DR, CCR2, and 
CCR5 on monocyte subsets of a sarcoidosis patient. (A) Monocytes are 
subdivided into 10 gates based on an increasing CD16 expression and a 
decreasing CD14 expression. Monocyte subset tracking stages of TNFR1 (B), 
TNFR2 (C), HLA-DR, (D), CCR2 (e), and CCR5 (F). The red gate number and the 
red line indicate the highest mean fluorescence intensity (MFI). Classical 
monocytes are identified by gate G1 (open histogram), intermediate monocytes 
by gates G2–G5 (filled histograms) and non-classical monocytes by gates  
G6–G10 (shaded histograms). The dotplot and all 5 histograms are representative 
for 52 individuals (sarcoidosis patients n = 39 and healthy controls n = 13).
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